Swiss National Bank Dice Therapeutics, Inc. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$25.86 - $46.71 $116,370 - $210,195	-4,500 Reduced 6.73%	62,400 $2.9 Million
Q1 2023 May 10, 2023	SELL	$26.05 - $32.31 $153,695 - $190,629	-5,900 Reduced 8.1%	66,900 $1.92 Million
Q4 2022 Feb 08, 2023	BUY	$19.77 - $42.23 $994,431 - $2.12 Million	50,300 Added 223.56%	72,800 $2.27 Million
Q2 2022 Aug 09, 2022	BUY	$13.19 - $22.1 $296,775 - $497,250	22,500 New	22,500 $349,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.